B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Glesatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Glesatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cabozantinib
15 shared targets
bms
11 shared targets
golvatinib
15 shared targets
tivozanib
14 shared targets
masitinib
12 shared targets
saracatinib
16 shared targets
dasatinib
11 shared targets
osi
14 shared targets
neflamapimod
10 shared targets
raf
18 shared targets
Loading evidence profile...

This evidence profile for Glesatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.